Farria, A. T., Mustachio, L. M., Akdemir, Z. H. C., & Dent, S. Y. (2019). GCN5 HAT inhibition reduces human Burkitt lymphoma cell survival through reduction of MYC target gene expression and impeding BCR signaling pathways. Oncotarget.
Chicago ZitierstilFarria, Aimee T., Lisa Maria Mustachio, Zeynep H. Coban Akdemir, und Sharon Y.R Dent. "GCN5 HAT Inhibition Reduces Human Burkitt Lymphoma Cell Survival Through Reduction of MYC Target Gene Expression and Impeding BCR Signaling Pathways." Oncotarget 2019.
MLA ZitierstilFarria, Aimee T., Lisa Maria Mustachio, Zeynep H. Coban Akdemir, und Sharon Y.R Dent. "GCN5 HAT Inhibition Reduces Human Burkitt Lymphoma Cell Survival Through Reduction of MYC Target Gene Expression and Impeding BCR Signaling Pathways." Oncotarget 2019.